Atrys Health, S.A. Logo

Atrys Health, S.A. (ATRY)

BME

Currency in EUR
2.53
-0.02 (-0.78%)

Real-time Data

07:00 AM

Day's Range

2.51
2.58

52 wk Range

2.31
3.59

Profile - ATRY - Atrys Health, S.A.

Profile

Mic Code

XMAD

Sector

Healthcare

Industry

Biotechnology

Employees

553


Atrys Health, S.A. is a Spain-based biomedical company specializing in precision diagnostic services and oncology treatments. Founded in 2007 and headquartered in Madrid, it operates through segments including Diagnosis, Oncology, and Preventive Medicine, delivering integrated solutions like structural and molecular pathology, genetics, nuclear medicine, telemedicine in radiology, cardiology, ophthalmology, dermatology, and advanced therapies such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy. With over 2,200 professionals across eight countries, including Spain, Portugal, and Latin America, Atrys Health emphasizes a 360-degree approach from prevention to cancer treatment, leveraging technology for telediagnosis and personalized care. The company, formerly Althia Health, pioneered telemedicine and radiotherapy innovations, integrating 14 acquisitions since 2018 for robust growth in laboratory testing, tele-diagnostics, and corporate health plans. Classified in the healthcare sector's biotechnology industry, it supports hospitals, insurers, and businesses with research-driven services.

Profile Details

Type

Common Stock

Ceo

Ms. Isabel Lozano Fernandez

Address

Príncipe de Vergara 132

City

Madrid

State

MI

Zip

28002

Country

Spain

Phone

34 917 819 465

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.